Prolonged and symptomatic bradycardia following a single dose of fingolimod

Mult Scler. 2013 Jan;19(1):126-8. doi: 10.1177/1352458512447596. Epub 2012 Jun 22.

Abstract

Fingolimod-related bradycardia is usually asymptomatic, reaches its nadir within 6 hours post-dose and recovers spontaneously. Here we report the case of a 30-year-old MS patient with vagotonia who developed symptomatic bradycardia with 33 beats per minute at nadir 39 hours after a single dose of fingolimod. Bradycardia was responsive to atropine, but returned within 2 hours. Overall, it took a week until the patient recovered. Extended monitoring is advised in patients with symptomatic bradycardia.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bradycardia / chemically induced*
  • Fingolimod Hydrochloride
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Multiple Sclerosis / drug therapy*
  • Propylene Glycols / adverse effects*
  • Sphingosine / adverse effects
  • Sphingosine / analogs & derivatives*

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Fingolimod Hydrochloride
  • Sphingosine